Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of GB18 injection in healthy participants, sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• GB18 Injection (GB18)

Snippet

Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. | Conditions: Cancer Cachexia (CC), Cancer Cachexia | Phase 1 | Status: RECRUITING